Literature DB >> 21862724

Mitochondrial dysfunction and insulin resistance from the outside in: extracellular matrix, the cytoskeleton, and mitochondria.

Dawn K Coletta1, Lawrence J Mandarino.   

Abstract

Insulin resistance in skeletal muscle is a prominent feature of obesity and type 2 diabetes. The association between mitochondrial changes and insulin resistance is well known. More recently, there is growing evidence of a relationship between inflammation, extracellular remodeling, and insulin resistance. The intent of this review is to propose a potentially novel mechanism for the development of insulin resistance, focusing on the underappreciated connections among inflammation, extracellular remodeling, cytoskeletal interactions, mitochondrial function, and insulin resistance in human skeletal muscle. Several sources of inflammation, including expansion of adipose tissue resulting in increased lipolysis and alterations in pro- and anti-inflammatory cytokines, contribute to the insulin resistance observed in obesity and type 2 diabetes. In the experimental model of lipid oversupply, an inflammatory response in skeletal muscle leads to altered expression extracellular matrix-related genes as well as nuclear encoded mitochondrial genes. A similar pattern also is observed in "naturally" occurring insulin resistance in muscle of obese nondiabetic individuals and patients with type 2 diabetes mellitus. More recently, alterations in proteins (including α-actinin-2, desmin, proteasomes, and chaperones) involved in muscle structure and function have been observed in insulin-resistant muscle. Some of these cytoskeletal proteins are mechanosignal transducers that allow muscle fibers to sense contractile activity and respond appropriately. The ensuing alterations in expression of genes coding for mitochondrial proteins and cytoskeletal proteins may contribute to the mitochondrial changes observed in insulin-resistant muscle. These changes in turn may lead to a reduction in fat oxidation and an increase in intramyocellular lipid, which contributes to the defects in insulin signaling in insulin resistance.

Entities:  

Mesh:

Year:  2011        PMID: 21862724      PMCID: PMC3214002          DOI: 10.1152/ajpendo.00363.2011

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  61 in total

Review 1.  LIM proteins: association with the actin cytoskeleton.

Authors:  T Khurana; B Khurana; A A Noegel
Journal:  Protoplasma       Date:  2002-02       Impact factor: 3.356

Review 2.  Toll-like receptors and innate immunity.

Authors:  R Medzhitov
Journal:  Nat Rev Immunol       Date:  2001-11       Impact factor: 53.106

3.  Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment.

Authors:  Raghavakaimal Sreekumar; Panagiotis Halvatsiotis; Jill Coenen Schimke; K Sreekumaran Nair
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

Review 4.  Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways.

Authors:  D Hwang
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

5.  Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle.

Authors:  K Cusi; K Maezono; A Osman; M Pendergrass; M E Patti; T Pratipanawatr; R A DeFronzo; C R Kahn; L J Mandarino
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

6.  Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes.

Authors:  David E Kelley; Jing He; Elizabeth V Menshikova; Vladimir B Ritov
Journal:  Diabetes       Date:  2002-10       Impact factor: 9.461

7.  Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.

Authors:  Jiandie Lin; Hai Wu; Paul T Tarr; Chen-Yu Zhang; Zhidan Wu; Olivier Boss; Laura F Michael; Pere Puigserver; Eiji Isotani; Eric N Olson; Bradford B Lowell; Rhonda Bassel-Duby; Bruce M Spiegelman
Journal:  Nature       Date:  2002-08-15       Impact factor: 49.962

8.  Insulin-resistant muscle is exercise resistant: evidence for reduced response of nuclear-encoded mitochondrial genes to exercise.

Authors:  Elena De Filippis; Guy Alvarez; Rachele Berria; Kenneth Cusi; Sarah Everman; Christian Meyer; Lawrence J Mandarino
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-01-08       Impact factor: 4.310

9.  PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.

Authors:  Vamsi K Mootha; Cecilia M Lindgren; Karl-Fredrik Eriksson; Aravind Subramanian; Smita Sihag; Joseph Lehar; Pere Puigserver; Emma Carlsson; Martin Ridderstråle; Esa Laurila; Nicholas Houstis; Mark J Daly; Nick Patterson; Jill P Mesirov; Todd R Golub; Pablo Tamayo; Bruce Spiegelman; Eric S Lander; Joel N Hirschhorn; David Altshuler; Leif C Groop
Journal:  Nat Genet       Date:  2003-07       Impact factor: 38.330

10.  Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1.

Authors:  Mary Elizabeth Patti; Atul J Butte; Sarah Crunkhorn; Kenneth Cusi; Rachele Berria; Sangeeta Kashyap; Yoshinori Miyazaki; Isaac Kohane; Maura Costello; Robert Saccone; Edwin J Landaker; Allison B Goldfine; Edward Mun; Ralph DeFronzo; Jean Finlayson; C Ronald Kahn; Lawrence J Mandarino
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 12.779

View more
  41 in total

Review 1.  The Vasculature in Prediabetes.

Authors:  David H Wasserman; Thomas J Wang; Nancy J Brown
Journal:  Circ Res       Date:  2018-04-13       Impact factor: 17.367

Review 2.  Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations.

Authors:  Christoph Hoffmann; Cora Weigert
Journal:  Cold Spring Harb Perspect Med       Date:  2017-11-01       Impact factor: 6.915

3.  Lipid overload: trigger or consequence of mitochondrial oxidative stress in ventilator-induced diaphragmatic dysfunction?

Authors:  Emilia Lecuona; Catherine S Sassoon; Esther Barreiro
Journal:  Am J Respir Crit Care Med       Date:  2012-12-01       Impact factor: 21.405

4.  Urethral striated muscle and extracellular matrix morphological characteristics among mildly diabetic pregnant rats: translational approach.

Authors:  Fernanda Piculo; Gabriela Marini; Angélica Mércia Pascon Barbosa; Débora Cristina Damasceno; Selma Maria Michelin Matheus; Sérgio Luis Felisbino; Firouz Daneshgari; Marilza Vieira Cunha Rudge
Journal:  Int Urogynecol J       Date:  2013-09-17       Impact factor: 2.894

Review 5.  Adaptive immunity in obesity and insulin resistance.

Authors:  Henrike Sell; Christiane Habich; Juergen Eckel
Journal:  Nat Rev Endocrinol       Date:  2012-07-31       Impact factor: 43.330

6.  Mitofusin-2 ameliorates high-fat diet-induced insulin resistance in liver of rats.

Authors:  Ke-Xin Gan; Chao Wang; Jin-Hu Chen; Chun-Jing Zhu; Guang-Yao Song
Journal:  World J Gastroenterol       Date:  2013-03-14       Impact factor: 5.742

7.  Effects of vildagliptin versus sitagliptin, on cardiac function, heart rate variability and mitochondrial function in obese insulin-resistant rats.

Authors:  Nattayaporn Apaijai; Hiranya Pintana; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

Review 8.  Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.

Authors:  Steven H Zeisel
Journal:  Clin Chem Lab Med       Date:  2013-03-01       Impact factor: 3.694

Review 9.  Secondary muscle pathology and metabolic dysregulation in adults with cerebral palsy.

Authors:  Mark D Peterson; Paul M Gordon; Edward A Hurvitz; Charles F Burant
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-08-21       Impact factor: 4.310

10.  Insight into the impact of dietary saturated fat on tissue-specific cellular processes underlying obesity-related diseases.

Authors:  Reilly T Enos; Kandy T Velázquez; E Angela Murphy
Journal:  J Nutr Biochem       Date:  2014-03-12       Impact factor: 6.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.